glucagon like peptide 1 glp 1 receptor agonist Central glucagon-like activation inhibits Toll-like receptor agonist-induced inflammation Glucagon-like peptide-1 receptor co-agonists for
Description
GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health

(2025) explores current evidence, challenges, and future perspectives in managing surgical patients on GLP-1R agonists

Full-dose, dual-hormone GLP-1 and GIP therapy, provider-led and built for women

Only one of those is GLP-1

Here's what researchers found.

They also offer the
